SVX-1-targeting LSP vaccine (Vaxeal)

N/A

Report date: 2025/03/20 15:21:13

Base Information

Drug NameSVX-1-targeting LSP vaccine (Vaxeal)
Drug Alias Namecancer antigen program (Vaxeal)SVX-1-targeting long synthetic peptide vaccine (Vaxeal)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVaxeal Holding SA
China Registration ClassN/A

Develop Information

Active CompaniesVaxeal Holding SA
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A